Plasma levels of cyclic GMP and endothelin in postmenopausal women with unstable coronary artery disease

REFERENCES

• CASS Study Group. National Heart, Lung and Blood Institute Coronary Artery Surgery Study (CASS). Circulation 1981; 63 (Monograph 79).
   Google Scholar
• Ahlner J, Andersson R, Axelsson K, Bergdahl B, Dahlstrom U, Swahn E. Decreased plasma levels of cyclic GMP in patients with chest pain and angiographically normal coronary arteries. Klin Wochenschr 1988; 66: 494–7.
   PubMedGoogle Scholar
• Waldman S, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev 1987; 39: 163–96.
   PubMed Web of Science ®Google Scholar
• Broadus A, Kaminsky N, Hardman J, Sutherland E, Liddle G. Kinetic parameters and renal clearances of plasma adenosine 3',5'-monopho-sphate and guanosine 3',5'-monophosphate in man. J Clin Invest 1970; 49: 2222–36.
   Google Scholar
• Endothelins [Review]. Lancet 1991; 337: 79–81.
   Google Scholar
• Haynes W, Webb D. Endothelin: a long-acting local constrictor hormone. Br J Hosp Med 1992; 47: 340–9.
   Google Scholar
• Wieczorek I, Haynes W, Webb D, Ludlam C, Fox K. Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. Br Heart J 1994; 72: 436–41.
   Google Scholar
• Yasuda M, Kohno M, Tahara A, et al. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 1990; 119: 801–6.
   PubMed Web of Science ®Google Scholar
• Stewart J, Nisbet J, Davies M. Plasma endothelin in coronary venous blood from patients with either stable or unstable angina. Br Heart J 1991; 66: 7–9.
   Google Scholar
• Brehm BR, Buttcher E, Beyer ME, Hoffmeister HM. Comparison of circulating endothelin-1 and big endothelin-1 levels in unstable versus stable angina pectoris. J Cardiovasc Pharm 1998; 31 Suppl 1: S90–3.
   Google Scholar
• Kaski J, Elliott P, Salomone 0, et al. Concentra-tion of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 1995; 74: 620–4.
   Google Scholar
• Hoffmann E, Assennato P, Donatelli M, Colletti I, Valenti TM. Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angio-grams. Am Heart J 1998; 135: 684–8.
   Google Scholar
• Michelakakis N, Petropoulou E, Lazaros G, et al. Comparison of endothelin-1 levels at rest and during exercise between patients with cardiac syndrome-x and healthy people. Acta Cardiol 1998; 53: 3–6.
   Google Scholar
• Kaski J, Cox I, Crook J, et al. Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries. Coronary Artery Disease Research Group. Am Heart J 1998; 136: 412–7.
   Google Scholar
• Low-molecular-weight heparin during instability in coronary artery disease. Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet 1996; 347: 561–8.
   Google Scholar
• Axelsson K, Bomefeldt K, Norlander B, Wikberg J. Attomole sensitive radioimmunoassay for cyclic GMP. Sec Mess Phosphoprot 1988; 12: 145— 54.
   Google Scholar
• Karlsson J, Bjorkholm A, Nylander E, Ohlsson J, Swahn E, Wallentin L. ST-changes in ECG at rest or during exercise indicate a high risk of severe coronary lesions after an episode of unstable coronary artery disease. Int J Cardiol 1993; 42: 47–55.
   PubMed Web of Science ®Google Scholar
• Anderson T, Uehata A, Gerhard M, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235–41.
   PubMed Web of Science ®Google Scholar
• Wiedermann J, Schwartz A, Apfelbaum M. Anatomic and physiologic heterogeneity in patients with syndrome X: an intravascular ultrasound study. J Am Coll Cardiol 1995; 25: 1310–7.
   Google Scholar
• Management of stable angina pectoris. Recom-mendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997; 18: 394 — 413.
   Google Scholar
• Kyriakides Z, Markianos M, Iliodromitis E, Kremastinos D. Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischaemia. Eur Heart J 1995; 16: 894–8.
   Google Scholar
• Qiu S, Theroux P, Marcil M, Solymoss B. Plasma endothelin-1 levels in stable and unstable angina. Cardiology 1993; 82: 12–9.
   Google Scholar
• Matsuyama K, Yasue H, Okumura K, et al. Increased plasma level of endothelin-1-like immu-noreactivity during coronary spasm in patients with coronary spastic angina. Am J Cardiol 1991; 68: 991–5.
   Google Scholar
• Miyauchi T, Yanagisawa M, Tomizawa T, et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarc-tion. Lancet 1989; 2: 53–4.
   PubMed Web of Science ®Google Scholar
• Polderman K, Stehouwer C, van KG, Dekker G, Verheugt F, Gooren L. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993; 118: 429–32.
   PubMed Web of Science ®Google Scholar
• Ylikorkala 0, Orpana A, Puolakka J, Pyorala T, Viinikka L. Postmenopausal hormonal replace-ment decreases plasma levels of endothelin-1. J Clin Endocrinol Metab 1995; 80: 3384–7.
   Google Scholar
• Lerman A, Holmes DJ, Bell M, Garratt K, Nishimura R, Burnett JJ. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92: 2426–31.
   PubMed Web of Science ®Google Scholar
• Zeiher A, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995; 91: 941–7.
   Google Scholar